XML 101 R89.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Plans - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
11 Months Ended 12 Months Ended
Dec. 12, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Stock-based compensation expense     $ 1,765 $ 44,812
weighted-average grant date fair value of options granted     $ 3.43 $ 0.81
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 5,700 $ 9,900
Amount of cost not yet recognized for nonvested award   $ 2,400   $ 2,400
Weighted-average period over which cost not yet recognized        1 year 11 months 15 days
Share based compensation stock options granted       1,750,000
Common stock, capital shares reserved for future issuance   37,422,305   37,422,305
Restricted Stock Units        
Stock-based compensation expense   $ 0   $ 42,700
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 0 35,000
Amount of cost not yet recognized for nonvested award   $ 41,900   $ 41,900
Weighted-average period over which cost not yet recognized        2 years 10 months 6 days
Vested       7,007,789
Common stock, capital shares reserved for future issuance   11,332,591   11,332,591
Restricted Stock Awards        
Stock-based compensation expense       $ 600
Vested       120,000
CEO Award [Member]        
Share based compensation stock options vesting period 3 years      
Share based compensation stock options granted 500,000      
Common stock exercise price $ 0.96      
CEO Award [Member] | Chief Executive Officer [Member]        
Share based compensation stock options granted 1,250,000      
Two Thousand Thirteen Equity Incentive Plan [Member] | CEO Award [Member]        
Share based compensation stock options granted 1,750,000      
2022 Equity Incentive Plan        
Percentage of the common stock of all classes outstanding on preceding year       5.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   18,332,215   18,332,215
Common stock, capital shares reserved for future issuance   4,748,116   4,748,116